A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies (NCT06600789)
A Modular, Multi-Part, Multi-Arm, Phase 1/2 Study to Evaluate the Safety and Tolerability of CT7439 Alone and in Combination With Anticancer Treatments in Participants With Solid Malignancies
🩺 Plain-English Summary (8th-Grade Level)
This modular, multi-part, multi-arm, Phase 1/2, FIH study allows the evaluation of the safety and tolerability of CT7439, dosed as a monotherapy and in combination with anticancer treatment in participants with solid malignancies.
Who can join: Review the eligibility criteria below.
Location: Research site 03 — Dallas, Texas
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Research site 03 — Dallas, Texas
- Research site 01 — San Antonio, Texas
- Research site 02 — Fairfax, Virginia
- Research site 05 — Manchester,
- Research site 04 — Oxford,
- Research site 06 — Sutton,
📞 Contact the Study Coordinator
Phone: +353 1 5996873
Email: hello@carricktherapeutics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Solid Malignancies
- Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens — Calgary, Alberta
- A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer — Palo Alto, California
- A Phase 1 Study of IM-1021 in Participants With Advanced Cancer — Duarte, California
Explore by condition: All Solid Malignancies clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.